Cargando…
Remission of Anti-laminin 332 Mucous Membrane Pemphigoid Associated with Non-small Cell Lung Cancer after Therapy with Rituximab and Intravenous Immunoglobulin
Autores principales: | TARNOWIETZKI, Evelyne, PETERS, Thorsten, KRAUS, Lea, SCHMIDT, Enno, SCHARFFETTER-KOCHANEK, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274920/ https://www.ncbi.nlm.nih.gov/pubmed/32852563 http://dx.doi.org/10.2340/00015555-3621 |
Ejemplares similares
-
Anti-Laminin 332-Type Mucous Membrane Pemphigoid
por: Shi, Luhuai, et al.
Publicado: (2022) -
Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid
por: Goletz, Stephanie, et al.
Publicado: (2021) -
Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid
por: Chiorean, Roxana, et al.
Publicado: (2018) -
Increased Fibrosis in a Mouse Model of Anti-Laminin 332 Mucous Membrane Pemphigoid Remains Unaltered by Inhibition of Aldehyde Dehydrogenase
por: Patzelt, Sabrina, et al.
Publicado: (2022) -
Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement
por: Quattri, Eleonora, et al.
Publicado: (2022)